Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Dosage Regimens: Partial Pharmacokinetic Parameters01:01

Dosage Regimens: Partial Pharmacokinetic Parameters

96
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
96
Prescription, Nonprescription and Orphan Drugs01:02

Prescription, Nonprescription and Orphan Drugs

1.1K
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
1.1K
Drug Products: Biologics, Biosimilars and Interchangeables01:28

Drug Products: Biologics, Biosimilars and Interchangeables

175
Body:Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
175
Dosage Regimen: Individualization01:24

Dosage Regimen: Individualization

115
Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
115
Drug Administration and Therapy Phases: Overview01:26

Drug Administration and Therapy Phases: Overview

1.1K
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
1.1K
Healthcare Agencies II01:17

Healthcare Agencies II

966
There are various healthcare agencies in the United States—some of which are managed by religious institutions and others by different government branches.
Parish nursing is a growing specialty nursing profession that focuses on holistic healthcare, health promotion, and illness prevention. It blends professional nursing practice with a health ministry, focusing on health and healing within the context of a Christian community. Parish nurses serve as health educators, referral sources,...
966

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Assessment and Clinical Management of Patients With Atopic Dermatitis Undergoing Patch Testing: Recommendations From an International Electronic Delphi Consensus.

Dermatitis : contact, atopic, occupational, drug·2026
Same author

Global barriers to sexual health, pregnancy, and breastfeeding in hidradenitis suppurativa.

International journal of women's dermatology·2026
Same author

Increased Risk of Deep Vein Thrombosis and Pulmonary Embolism in Hidradenitis Suppurativa Patients With Down Syndrome: A Retrospective Cohort Study.

International journal of dermatology·2026
Same author

Application Site Adverse Events of Topical Nonsteroidal Immunomodulators: A Post-Marketing Analysis of the FDA Adverse Event Reporting System.

International journal of dermatology·2026
Same author

The Impact of Chronic Spontaneous Urticaria on Sleep-A Systematic Review.

Dermatology and therapy·2026
Same author

The Effects of Immune Checkpoint Inhibitors on Hidradenitis Suppurativa: A Scoping Review.

Skin appendage disorders·2026
Same journal

Commentary on exploring the mechanism of differential responses to combination therapy in melasma: pigmentary versus mixed pigmentary-vascular types-a clinical study based on interaction analysis.

The Journal of dermatological treatment·2026
Same journal

Clinical response and time to improvement with 308-nm excimer laser therapy in scarring alopecia: a retrospective cohort study.

The Journal of dermatological treatment·2026
Same journal

Stapokibart provides significant improvements in signs and symptoms of atopic dermatitis irrespective of prior systemic treatment: a post-hoc analysis of a phase 3 trial.

The Journal of dermatological treatment·2026
Same journal

Active surveillance for basal cell carcinoma: experiences of patients and proxies.

The Journal of dermatological treatment·2026
Same journal

Severe cutaneous adverse reactions associated with systemic antibiotics in acne vulgaris: a systematic review.

The Journal of dermatological treatment·2026
Same journal

Intralesional human papillomavirus vaccination for cutaneous verrucae: a systematic review and meta-analysis of therapeutic efficacy.

The Journal of dermatological treatment·2026
See all related articles

Related Experiment Video

Updated: Dec 23, 2025

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
19:57

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

19.0K

Demystifying pharmaceutical patient assistance programs.

Erin K Collier1, Kyla N Price2, Jennifer L Hsiao3

  • 1David Geffen School of Medicine, University of California, Los Angeles, CA, USA.

The Journal of Dermatological Treatment
|April 21, 2020
PubMed
Summary
This summary is machine-generated.

Patient assistance programs (PAPs) help patients afford high-cost prescription drugs for chronic skin conditions. Navigating these programs presents challenges for patients and clinicians, requiring better understanding and support.

Keywords:
Dermatology medicationsfinancial assistancepatient assistance programspharmaceutical companiesprescription drugs

More Related Videos

Multidisciplinary Approach to Obesity Management: A Case Report
05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

814
A Mass Spectrometry-Based Approach to Identify Phosphoprotein Phosphatases and their Interactors
10:17

A Mass Spectrometry-Based Approach to Identify Phosphoprotein Phosphatases and their Interactors

Published on: April 29, 2022

2.7K

Related Experiment Videos

Last Updated: Dec 23, 2025

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
19:57

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

19.0K
Multidisciplinary Approach to Obesity Management: A Case Report
05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

814
A Mass Spectrometry-Based Approach to Identify Phosphoprotein Phosphatases and their Interactors
10:17

A Mass Spectrometry-Based Approach to Identify Phosphoprotein Phosphatases and their Interactors

Published on: April 29, 2022

2.7K

Area of Science:

  • Dermatology
  • Health Economics
  • Health Policy

Background:

  • High prescription drug costs create a significant financial burden within the U.S. healthcare system.
  • Patients with chronic dermatologic conditions frequently need costly, long-term medications.
  • Pharmaceutical companies offer patient assistance programs (PAPs) to improve access to expensive, brand-name drugs.

Purpose of the Study:

  • To explore the utility, criteria, and challenges associated with patient assistance programs (PAPs).
  • To provide practical guidance for dermatologists assisting medically indigent patients with medication access.
  • To enhance understanding of PAPs for improved patient outcomes in dermatology.

Main Methods:

  • Review of existing literature on patient assistance programs.
  • Analysis of common criteria and application processes for major PAPs.
  • Discussion of challenges faced by patients and healthcare providers in navigating PAPs.

Main Results:

  • PAPs offer a vital pathway for accessing necessary but expensive dermatologic medications.
  • Navigating the diverse requirements and processes of multiple PAPs can be complex and time-consuming.
  • Clearer guidelines and streamlined processes are needed to optimize PAP utilization.

Conclusions:

  • Patient assistance programs are crucial for managing financial toxicity in dermatologic care.
  • Dermatologists require practical tools and knowledge to effectively guide patients through PAPs.
  • Addressing PAP navigation challenges can improve medication adherence and health equity for vulnerable populations.